BGI-Shenzhen, Shenzhen 518083, China.
College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, China.
Anal Chem. 2022 Jan 18;94(2):918-926. doi: 10.1021/acs.analchem.1c03678. Epub 2021 Dec 1.
The lack of an efficient method for the identification of tumor antigen-specific T cell receptors (TCRs) impedes the development of T cell-based cancer immunotherapies. Here, we introduce a droplet-based microfluidic platform for function-based screening and sorting of tumor antigen-specific T cells with high throughput. We built a reporter cell line by co-transducing the TCR library and reporter genes at the downstream of TCR signaling, and reporter cells fluoresced upon functionally binding with antigens. We co-encapsulated reporter cells and antigen-presenting cells in droplets to allow for stimulation on a single-cell level. Functioning reporter cells specific against the antigen were identified in the microfluidic channel based on the fluorescent signals of the droplets, which were immediately sorted out using dielectrophoresis. We validated the reporter system and sorting results using flow cytometry. We then performed single-cell RNA sequencing on the sorted cells to further validate this platform and demonstrate the compatibility with genetic characterizations. Our platform provides a means for precise and efficient T cell immunotherapy, and the droplet-based high-throughput TCR screening method could potentially facilitate immunotherapeutic screening and promote T cell-based anti-tumor therapies.
缺乏有效的肿瘤抗原特异性 T 细胞受体 (TCR) 鉴定方法,阻碍了基于 T 细胞的癌症免疫疗法的发展。在这里,我们引入了一种基于液滴的微流控平台,用于高通量的基于功能的肿瘤抗原特异性 T 细胞的筛选和分选。我们通过共转导 TCR 文库和 TCR 信号下游的报告基因构建了报告细胞系,并且报告细胞在与抗原功能性结合时会发出荧光。我们将报告细胞和抗原呈递细胞共包封在液滴中,以允许在单细胞水平上进行刺激。基于液滴的荧光信号,在微流道中鉴定出针对抗原的功能型报告细胞,然后使用电动力学方法立即对其进行分选。我们使用流式细胞术验证了报告系统和分选结果。然后,我们对分选细胞进行单细胞 RNA 测序,以进一步验证该平台并证明其与遗传特征的兼容性。我们的平台为精确和有效的 T 细胞免疫疗法提供了一种手段,基于液滴的高通量 TCR 筛选方法有可能促进免疫治疗筛选并推动基于 T 细胞的抗肿瘤疗法。